{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:36:28Z","timestamp":1764603388701,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG034676"],"award-info":[{"award-number":["R01 AG034676"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR46849"],"award-info":[{"award-number":["R01 AR46849"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10067-016-3335-5","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T04:24:57Z","timestamp":1466655897000},"page":"2427-2436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014"],"prefix":"10.1007","volume":"35","author":[{"given":"Jorge A.","family":"Zamora-Legoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Myasoedova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"3335_CR1","unstructured":"Gu Q, Dillon CF, Burt VL (2010) Prescription drug use continues to increase: U.S. prescription drug data for 2007\u20132008. NCHS Data Brief (42):1\u20138"},{"issue":"9","key":"3335_CR2","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1345\/aph.10351","volume":"35","author":"T Jorgensen","year":"2001","unstructured":"Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K (2001) Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35(9):1004\u20131009","journal-title":"Ann Pharmacother"},{"key":"3335_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3947","author":"F Zhang","year":"2015","unstructured":"Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD (2015) Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf. doi:\n                    10.1002\/pds.3947","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"3335_CR4","first-page":"19","volume":"10","author":"K Smolina","year":"2014","unstructured":"Smolina K, Morgan S (2014) The drivers of overspending on prescription drugs in Quebec. Healthc Policy 10(2):19\u201326","journal-title":"Healthc Policy"},{"key":"3335_CR5","unstructured":"Organization WH (2016) Trade, foreign policy, diplomacy and health. Pharm Ind"},{"issue":"17","key":"3335_CR6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999\u20132012. Jama 314(17):1818\u20131831. doi:\n                    10.1001\/jama.2015.13766","journal-title":"Jama"},{"issue":"7","key":"3335_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.mayocp.2013.04.021","volume":"88","author":"W Zhong","year":"2013","unstructured":"Zhong W, Maradit-Kremers H, St Sauver JL, Yawn BP, Ebbert JO, Roger VL, Jacobson DJ, McGree ME, Brue SM, Rocca WA (2013) Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc 88(7):697\u2013707. doi:\n                    10.1016\/j.mayocp.2013.04.021","journal-title":"Mayo Clin Proc"},{"key":"3335_CR8","unstructured":"Services USDoHH (2016) Observations on trends in prescription drug spending 2016"},{"issue":"4","key":"3335_CR9","first-page":"503","volume":"30","author":"RE Cossman","year":"2008","unstructured":"Cossman RE, Cossman JS, James WL, Blanchard T, Thomas RK, Pol LG, Cosby AG, Mirvis DM (2008) Evaluating heart disease prescriptions-filled as a proxy for heart disease prevalence rates. J Health Hum Serv Adm 30(4):503\u2013528","journal-title":"J Health Hum Serv Adm"},{"issue":"1","key":"3335_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11926-012-0300-4","volume":"15","author":"YC Lee","year":"2013","unstructured":"Lee YC (2013) Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheumatol Rep 15(1):300. doi:\n                    10.1007\/s11926-012-0300-4","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"3335_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11883-015-0557-y","volume":"18","author":"H Teague","year":"2016","unstructured":"Teague H, Mehta NN (2016) The link between inflammatory disorders and coronary heart disease: a look at recent studies and novel drugs in development. Curr Atheroscler Rep 18(1):3. doi:\n                    10.1007\/s11883-015-0557-y","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"3335_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.6061\/clinics\/2015(02)04","volume":"70","author":"MC Lin","year":"2015","unstructured":"Lin MC, Guo HR, Lu MC, Livneh H, Lai NS, Tsai TY (2015) Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study. Clinics (Sao Paulo) 70(2):91\u201396. doi:\n                    10.6061\/clinics\/2015(02)04","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"3335_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","volume":"110","author":"CS Crowson","year":"2012","unstructured":"Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE (2012) Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 110(3):420\u2013424. doi:\n                    10.1016\/j.amjcard.2012.03.044","journal-title":"Am J Cardiol"},{"issue":"5","key":"3335_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10067-013-2482-1","volume":"34","author":"H Katada","year":"2015","unstructured":"Katada H, Yukawa N, Urushihara H, Tanaka S, Mimori T, Kawakami K (2015) Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan. Clin Rheumatol 34(5):949\u2013956. doi:\n                    10.1007\/s10067-013-2482-1","journal-title":"Clin Rheumatol"},{"key":"3335_CR15","unstructured":"CDC (2015) Arthritis-related statistics. \n                    http:\/\/www.cdc.gov\/arthritis\/data_statistics\/arthritis_related_stats.htm"},{"issue":"3","key":"3335_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4065\/71.3.266","volume":"71","author":"LJ Melton 3rd","year":"1996","unstructured":"Melton LJ 3rd (1996) History of the Rochester epidemiology project. Mayo Clin Proc 71(3):266\u2013274. doi:\n                    10.1016\/S0025-6196(11)63966-9","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3335_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/ije\/dys195","volume":"41","author":"JL St Sauver","year":"2012","unstructured":"St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Pankratz JJ, Brue SM, Rocca WA (2012) Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 41(6):1614\u20131624. doi:\n                    10.1093\/ije\/dys195","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3335_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3335_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613\u2013619","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"3335_CR20","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation 131(4):e29\u2013e322. doi:\n                    10.1161\/CIR.0000000000000152","journal-title":"Circulation"},{"key":"3335_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3239-4","author":"JA Zamora-Legoff","year":"2016","unstructured":"Zamora-Legoff JA, Achenbach SJ, Crowson CS, Krause ML, Davis JM 3rd, Matteson EL (2016) Opioid use in patients with rheumatoid arthritis 2005\u20132014: a population-based comparative study. Clin Rheumatol. doi:\n                    10.1007\/s10067-016-3239-4","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3335_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/ard.2009.115717","volume":"69","author":"TE Toms","year":"2010","unstructured":"Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP, Symmons DP, Nightingale P, Metsios GS, Kitas GD (2010) Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 69(4):683\u2013688. doi:\n                    10.1136\/ard.2009.115717","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3335_CR23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3899\/jrheum.121302","volume":"40","author":"BM Akkara Veetil","year":"2013","unstructured":"Akkara Veetil BM, Myasoedova E, Matteson EL, Gabriel SE, Crowson CS (2013) Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol 40(7):1082\u20131088. doi:\n                    10.3899\/jrheum.121302","journal-title":"J Rheumatol"},{"issue":"10","key":"3335_CR24","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jacc.2010.10.034","volume":"57","author":"AA Hussein","year":"2011","unstructured":"Hussein AA, Uno K, Wolski K, Kapadia S, Schoenhagen P, Tuzcu EM, Nissen SE, Nicholls SJ (2011) Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol 57(10):1220\u20131225. doi:\n                    10.1016\/j.jacc.2010.10.034","journal-title":"J Am Coll Cardiol"},{"key":"3335_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018383","author":"G Thanassoulis","year":"2016","unstructured":"Thanassoulis G, Williams K, Kimler Altobelli K, Pencina MJ, Cannon CP, Sniderman AD (2016) Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease. Circulation. doi:\n                    10.1161\/CIRCULATIONAHA.115.018383","journal-title":"Circulation"},{"key":"3335_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew039","author":"DF van Breukelen-van der Stoep","year":"2016","unstructured":"van Breukelen-van der Stoep DF, van Zeben D, Klop B, van de Geijn GM, Janssen HJ, van der Meulen N, De Vries MA, Hazes M, Birnie E, Castro Cabezas M (2016) Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology (Oxford). doi:\n                    10.1093\/rheumatology\/kew039","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"3335_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/acr.21986","volume":"65","author":"C Nannini","year":"2013","unstructured":"Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL, Bongartz T (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 65(8):1243\u20131250. doi:\n                    10.1002\/acr.21986","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3335_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52(1):53\u201361. doi:\n                    10.1093\/rheumatology\/kes305","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3335_CR29","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.27412","volume":"62","author":"EL Masso Gonzalez","year":"2010","unstructured":"Masso Gonzalez EL, Patrignani P, Tacconelli S, Garcia Rodriguez LA (2010) Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62(6):1592\u20131601. doi:\n                    10.1002\/art.27412","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3335_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Int Med 176(2):238\u2013246. doi:\n                    10.1001\/jamainternmed.2015.7193","journal-title":"JAMA Int Med"},{"issue":"9","key":"3335_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/aje\/kwq482","volume":"173","author":"JL St Sauver","year":"2011","unstructured":"St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA (2011) Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 173(9):1059\u20131068. doi:\n                    10.1093\/aje\/kwq482","journal-title":"Am J Epidemiol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3335-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:47:06Z","timestamp":1589442426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3335-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3335"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3335-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"13 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective cohort study was approved by the Mayo Clinic and Olmsted Medical Center Institutional Review Boards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was funded by a grant from the National Institutes of Health, NIAMS (R01 AR46849), and made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Grants\/financial supports"}}]}}